机构:[1]Committee of Reproductive Medicine,World Federation of Chinese Medicine Societies, Beijing, China[2]Department of Obstetrics and Gynecology, First Affiliated Hospital,Heilongjiang University of Chinese Medicine,Harbin, China[3]Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden[4]Outpatient Department, Xuzhou Maternal and Children’s Hospital, Xuzhou, China[5]Centre for Reproductive Medicine, Dalian Maternal and Children’s Centre, Dalian, China[6]Department of Infertility, Tanggu District Maternal and Children’s Hospital, Tianjin, China[7]Department of Obstetrics and Gynecology, Shanxi Province Hospital of Chinese Medicine, Taiyuan, China[8]Centre for Reproductive Medicine, Huaian Maternal and Children’s Hospital, Huaian, China[9]Department of Gynecology, Suzhou City Hospital of Chinese Medicine, Suzhou, China[10]Department of Gynecology, Second Hospital, Jiangxi University of Chinese Medicine, Nanchang, China (Liang)[11]Department of Chinese Medicine, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China[12]Department of Infertility, Liwan District Hospital of Chinese Medicine, Guangzhou, China[13]Department of Obstetrics and Gynecology, Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, China[14]Institute of Integrated Traditional andWestern Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan, China华中科技大学同济医学院附属同济医院[15]Department of Gynecology,Wenzhou City Hospital of Chinese Medicine,Wenzhou, China[16]Centre for Reproductive Medicine, Yuhuangding Hospital, Yantai, China[17]Department of Obstetrics and Gynecology, Daqing Longnan Hospital, Daqing, China[18]Department of Obstetrics and Gynecology, First Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, China[19]Department of Obstetrics and Gynecology, First Affiliated Hospital, Liaoning University of Chinese Medicine, Shenyang, China[20]Department of Gynecology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China[21]Department of Traditional Technology, Guangdong Province Hospital of Chinese Medicine, Guangzhou, China大德路总院传统疗法科大德路总院传统疗法科广东省中医院[22]Department of Gynecology, Hangzhou City Hospital of Chinese Medicine, Hangzhou, China[23]Centre for Reproductive Medicine, Zhejiang Province Hospital of Integrative Medicine, Hangzhou, China[24]Centre for Reproductive Medicine, Daqing Oilfield General Hospital, Daqing, China[25]Department of Obstetrics and Gynecology, Hubei Province Hospital of Chinese Medicine,Wuhan, China[26]Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Hong Kong, China[27]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China[28]School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China[29]Chinese Clinical Trial Registry, Shenzhen, China[30]Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China[31]Department of Obstetrics and Gynecology, The University of Hong Kong, Hong Kong, China[32]Department of Obstetrics and Gynecology, Pennsylvania State University, Hershey[33]Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut
IMPORTANCE Acupuncture is used to induce ovulation in some women with polycystic ovary syndrome, without supporting clinical evidence. OBJECTIVE To assess whether active acupuncture, either alone or combined with clomiphene, increases the likelihood of live births among women with polycystic ovary syndrome. DESIGN, SETTING, AND PARTICIPANTS A double-blind (clomiphene vs placebo), single-blind (active vs control acupuncture) factorial trial was conducted at 21 sites (27 hospitals) in mainland China between July 6, 2012, and November 18, 2014, with 10 months of pregnancy follow-up until October 7, 2015. Chinese women with polycystic ovary syndrome were randomized in a 1:1:1:1 ratio to 4 groups. INTERVENTIONS Active or control acupuncture administered twice a week for 30 minutes per treatment and clomiphene or placebo administered for 5 days per cycle, for up to 4 cycles. The active acupuncture group received deep needle insertion with combined manual and low-frequency electrical stimulation; the control acupuncture group received superficial needle insertion, no manual stimulation, and mock electricity. MAIN OUTCOMES AND MEASURES The primary outcome was live birth. Secondary outcomes included adverse events. RESULTS Among the 1000 randomized women (mean [SD] age, 27.9 [3.3] years; mean [SD] body mass index, 24.2 [4.3]), 250 were randomized to each group; a total of 926 women (92.6%) completed the trial. Live births occurred in 69 of 235 women (29.4%) in the active acupuncture plus clomiphene group, 66 of 236 (28.0%) in the control acupuncture plus clomiphene group, 31 of 223 (13.9%) in the active acupuncture plus placebo group, and 39 of 232 (16.8%) in the control acupuncture plus placebo group. There was no significant interaction between active acupuncture and clomiphene (P = .39), so main effects were evaluated. The live birth rate was significantly higher in the women treated with clomiphene than with placebo (135 of 471 [28.7%] vs 70 of 455 [15.4%], respectively; difference, 13.3%; 95% CI, 8.0% to 18.5%) and not significantly different between women treated with active vs control acupuncture (100 of 458 [21.8%] vs 105 of 468 [22.4%], respectively; difference, -0.6%; 95% CI, -5.9% to 4.7%). Diarrhea and bruising were more common in patients receiving active acupuncture than control acupuncture (diarrhea: 25 of 500 [5.0%] vs 8 of 500 [1.6%], respectively; difference, 3.4%; 95% CI, 1.2% to 5.6%; bruising: 37 of 500 [7.4%] vs 9 of 500 [1.8%], respectively; difference, 5.6%; 95% CI, 3.0% to 8.2%). CONCLUSIONS AND RELEVANCE Among Chinese women with polycystic ovary syndrome, the use of acupuncture with or without clomiphene, compared with control acupuncture and placebo, did not increase live births. This finding does not support acupuncture as an infertility treatment in such women.
基金:
National Public Welfare Projects for Chinese Medicine [201107005, 200807002]; Heilongjiang Province Foundation for Outstanding Youths [JC200804]; Intervention for PCOS Based on Traditional Chinese Medicine Theory-TianGui Disorder [2011TD006]; First Affiliated Hospital, Heilongjiang University of Chinese Medicine from National Clinical Trial Base in Chinese Medicine Special Projects [JDZX2012036, 2015B009]; National Key Discipline of Chinese Medicine in Gynecology; Heilongjiang Province "Longjiang Scholar" Program; Chinese "Thousand Talents Plan" scholarship
第一作者机构:[*1]Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China
共同第一作者:
通讯作者:
通讯机构:[1]Committee of Reproductive Medicine,World Federation of Chinese Medicine Societies, Beijing, China[2]Department of Obstetrics and Gynecology, First Affiliated Hospital,Heilongjiang University of Chinese Medicine,Harbin, China[*1]Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China
推荐引用方式(GB/T 7714):
Xiao-KeWu,Elisabet Stener-Victorin,Hong-Ying Kuang,et al.Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome A Randomized Clinical Trial[J].JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.2017,317(24):2502-2514.doi:10.1001/jama.2017.7217.
APA:
Xiao-KeWu,Elisabet Stener-Victorin,Hong-Ying Kuang,Hong-Li Ma,Jing-Shu Gao...&for the PCOSAct Study Group.(2017).Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome A Randomized Clinical Trial.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,317,(24)
MLA:
Xiao-KeWu,et al."Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome A Randomized Clinical Trial".JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 317..24(2017):2502-2514